评估认知干预对健康和轻度认知障碍成人的有效性:一个全面的雨元分析
Giuseppe Forte1, Francesca Favieri1, Ilaria Corbo1
1Department of Dynamic and Clinical Psychology, and Health Studies, Sapienza University of Rome, Rome, Italy.
Journal of aging research
|June 24, 2025
概括
认知干预显著改善认知功能,如老年人的记忆和执行功能,包括那些轻度认知障碍 (MCI). 这项研究证实了它们对健康衰老和临床前疾病的有效性.
科学领域:
- 老年学和认知神经科学
- 基于证据的干预措施用于认知健康.
背景情况:
- 众所周知,认知干预可以提高整个生命周期的认知功能.
- 对于它们对老年人,特别是那些患有轻度认知障碍 (MCI) 的因果影响的证据,需要严格的评估.
研究的目的:
- 进行一项综合元分析,以评估健康老年人和患有MCI的个人认知干预的因果证据.
- 综合现有元分析的发现,以确定认知干预的整体疗效.
主要方法:
- 在多个电子数据库 (CINAHL,Cochrane图书馆,PsycINFO,PubMed,Scopus,Web of Science) 进行了系统的搜索.
- 包括对健康老年人和患有MCI的个体孤立认知干预措施影响的元分析.
- 在9734个选的出版物中,从25个选定的元分析中获得的数据被统计分析.
主要成果:
- 在所有研究中都观察到认知干预对全球认知功能产生一致的积极影响.
- 与对照组相比,记忆力,执行功能,视觉空间能力和处理速度都有显著的改善.
- 效果大小虽然可变,但始终证明了这些干预措施的有效性.
结论:
- 认知干预是提高老年人认知功能的高效策略,包括那些患有MCI的人.
- 这些干预措施代表了管理临床前衰老和保持认知健康的有希望的方法.
- 这些发现支持将认知治疗纳入老年人群的临床实践.
更多相关视频
07:01Working Memory Training for Older Participants: A Control Group Training Regimen and Initial Intellectual Functioning Assessment
Published on: September 20, 2020
4.9K
06:58Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing
Published on: January 24, 2020
7.4K
相关概念视频
01:30Cognitive Development During Adulthood
303
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
303
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
214
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
214